-
-
-
-
-
-
-
Organogenesis Holding (ORGO) Met Primary Endpoint in Phase 3 Trial of ReNu
-
-
-
-
-
-
-
Monogram Orthopaedics (MGRM) Provides Regulatory Update Following Meeting with FDA
-
-
-
-
-
-
-
WAVE Life Sciences (WVE) Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency
-
-
-
-
-
-
-
ProMIS Neurosciences (PMN) Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies
-
-
-
-
-
-
-
Terns Pharmaceuticals (TERN) Reports Data from Ongoing Phase 1 Study of TERN-701
-
-
-
-
-
-
-
GE HealthCare (GEHC) Granted FDA Clearance for Portrait VSM
-
-
-
-
-
-
-
ZyVersa Therapeutics (ZVSA) Reports Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities
-
66,962 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.